InspireMD to Announce Third Quarter 2025 Financial Results
InspireMD (Nasdaq: NSPR) announced it will release its third quarter 2025 financial results on Tuesday, November 4, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
InspireMD (Nasdaq: NSPR) announced it will release its third quarter 2025 financial results on Tuesday, November 4, 2025.
The company will host a conference call and webcast on November 4, 2025 at 8:30 a.m. Eastern Time to review results and recent highlights. Domestic callers may dial 1-800-579-2543; international callers may dial 1-785-424-1789. Investors can join the live webinar via InspireMD’s website or the provided webcast registration link. A replay will be available shortly after the call and archived on the company website.
Details
News Market Reaction – NSPR
On Oct 22, the first trading day after this news, NSPR closed 4.68% below the previous close.
Data tracked by StockTitan Argus for the Oct 22 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MIAMI, Oct. 21, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that it will release its third quarter 2025 financial results on Tuesday, November 4, 2025. In conjunction with the release, InspireMD will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss its financial results and recent highlights.
Interested parties may access the live earnings call via telephone by dialing 1-800-579-2543 for domestic callers or 1-785-424-1789 for international callers. The live webinar may be accessed by visiting InspireMD’s website or by registering below. A replay of the webinar will be available shortly after the conclusion of the call and will be archived on InspireMD’s website.
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1738063&tp_key=c84683c4fd
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR.
We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.
Investor Contact:
Webb Campbell
Gilmartin Group LLC
Webb@gilmartinir.com
investor-relations@inspiremd.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.